Oppenheimer Reiterates Perform Rating on BioNTech (BNTX) following management changes
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
| (NASDAQ: BNTX) | Delayed: 95.84 -1.12 (1.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $96.96 | 52 Week High | $ | |||
| Open | $97.61 | 52 Week Low | $ | |||
| Day High | $98.60 | P/E | N/A | |||
| Day Low | $95.75 | EPS | $ | |||
| Volume | 1,276,990 | |||||
